Source link : https://www.newshealth.biz/health-news/adcs-for-breast-cancer-clear-benefits-manageable-risks/
Antibody drug conjugates (ADCs) — a class of targeted medications that combine monoclonal antibodies with cytotoxic payloads — are rapidly changing the treatment landscape for patients with metastatic breast cancer. These medications, which are designed to selectively deliver potent cytotoxic drugs to cancer cells expressing specific surface antigens such as human epidermal growth factor receptor […]
Author : News Health
Publish date : 2024-05-21 07:19:04
Copyright for syndicated content belongs to the linked Source.
in Health